Bone Biologics holds annual shareholder meeting

• Bone Biologics held its annual shareholder meeting on Sept. 28, 2026.
• Shareholders confirmed four director nominees to serve until the next annual meeting.
• Ratification of Weinberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026 passed.
• Approval was granted for a potential issuance of common shares underlying certain warrants tied to a July 7, 2026 agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bone Biologics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-044889), on September 29, 2026, and is solely responsible for the information contained therein.